"Re:Check": Are there more innovative cancer drugs in Latvia than in Lithuania and Estonia, as claimed by Prime Minister Siliņa?
Latvia's Prime Minister Siliņa claimed that Latvia offers more innovative cancer medications than Lithuania and Estonia, a statement that has been challenged by recent data.
The career and drugs, illness and daughters: all about Bianca Balti, guest of the fourth evening of Sanremo
Bianca Balti, a renowned Italian model, will be a guest on the fourth evening of the Sanremo Festival, following her battle with ovarian cancer and her influential modeling career.
Anvisa seizes counterfeit cancer drug, fake batch of Mounjaro, and bans 'hormonal chip' in the country
Brazil's health regulatory agency Anvisa has seized counterfeit batches of several drugs including Mounjaro and prohibited the compounding of hormonal implants.
AstraZeneca profit rises as cancer drug sales grow
AstraZeneca reported a 45% increase in net profit for 2025, driven by robust sales of cancer drugs and expansion in the U.S. and China.
Concern over the expectations created by Barbacid about pancreatic cancer: 'The announcement has gotten out of hand'
The National Center for Cancer Research (CNIO) has seen an unprecedented number of inquiries following Mariano Barbacid's announcement of successfully eliminating a type of pancreatic cancer in mice using a combination of three drugs.
GSK profit rises to £5.7bn as speciality medicines drive growth
GSK's net profit surged to £5.7 billion, primarily fueled by strong sales in specialty medicines like HIV and cancer drugs, as the company rebounds from previous legal challenges.
How Much Benefit Do Cancer Patients Get from Cheaper Drugs? What Experts Say
The 2026-27 central budget has announced the removal of basic customs duty on 17 cancer medications to reduce treatment costs, which experts have welcomed but caution that the real impact depends on implementation.
Great relief for cancer patients! Complete abolition of custom duty on 17 life-saving drugs
India's Finance Minister Nirmala Sitharaman announced in the 2026-27 budget the complete abolition of basic custom duty on 17 cancer drugs, making treatment for life-threatening diseases more affordable and accessible, along with significant rebates on import duties for rare diseases.
The new action plan of the CNIO includes the closure of cancer diagnosis units and the development of new drugs
The new phase of the National Center for Cancer Research (CNIO) involves closing cancer diagnosis units and focusing on the development of new drugs to enhance oncological research.
I'm dying - and losing friends too soon because we can't get vital drug
Sophie Blake, a terminally ill mother from Brighton with stage four breast cancer, expresses her anguish over losing friends and being denied a vital life-extending drug by the Government.
Ten new molecules developed at the IRB laboratory that could be the foundation for new cancer drugs
Scientists at the Ruđer Bošković Institute announced the development of nine new small molecules that may serve as the basis for future cancer drugs targeting tumors associated with the BRAF V600E genetic mutation.
The medicine cabinet for 2026: Ozempic's 'pill', multiple cancer therapies, and news in inflammatory pathologies
The article discusses the anticipated developments of leading drugs in 2026, focusing on GLP-1 agonists, new multi-target compounds, and advancements in treatments for obesity and diabetes, along with their expanding applications in other health conditions.